SugarMDs is thrilled to announce the highly anticipated return of its Advanced Glucose Support formula, available for purchase starting February 12th. With an improved formulation and an ...

Faron Pharmaceuticals (HEL:FARON)(LSE:FARN) - Strong efficacy and survival outcomes with bexmarilimab in high-risk MDS support Phase III advancement Median overall survival (mOS) of 13.4 months in r/r ...